UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News:
STRONG SALES INCREASE FOR ABSTRAL®
References made in this interim report relate to the Group unless otherwise stated. Figures in parentheses relate to the corresponding period in 2010.
For the period
· Royalty revenues from Abstral® sales in Europe rose to MSEK 30.4 (19.5).
· Introduction of Abstral in the US and Canada.
